There has been much written lately about the potential link between testosterone therapy and heart disease.
Some study's have shown an increased risk of heart problems but others have not. A group of American Endocrinologists recently called for a retraction of one of these papers that showed an increased risk.
A European Medicines Agency (EMA) has reviewed the evidence and has concluded that testosterone does not increase the risk of heart disease in patients with confirmed hypogonadism.
The FDA's final review is still pending. But until that time, the EMA's review is reassuring that testosterone treatment is probably safe for men symptomatic hypogonadism.